AIM ImmunoTech (AIMI) Earnings Date & Reports

AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate or unmet therapies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AIMI is expected to report earnings to -7 cents per share on August 19

AIM ImmunoTech AIMI Stock Earnings Reports

Q2'25

Est.

$-0.08

Q1'25

Beat

by $0.01

Q4'24

Missed

by $0.01

The last earnings report on May 15 showed earnings per share of -7 cents, beating the estimate of -9 cents. With 473.47 shares outstanding, the current market capitalization sits at 5.43M.

View a ticker or compare two or three

Compare

AIMI

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AIMI
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders

Industry Biotechnology

Profile

Fundamentals

Details